旋转的爱

Aneet Padda to Shoot for Shakti Shalini Right After College Exams_我的网站

偷心俏冤家

一 | Rising star Aneet Padda, who captured hearts with her debut in Saiyaara, the highest-grossing love story in Indian cinema, is now preparing for a different kind of challenge: her college final-year exams. The 22-year-old actor, hailed as the biggest Gen Z face in the country, will be appearing for her B.A. (Hons.) Political Science finals in December and January. A source close to the actor shared, “It’s inspiring how Aneet is managing everything so gracefully. Despite being a national sensation, she remains committed to her education. Her team is carefully structuring her schedule so she can focus on her exams while meeting professional commitments.; Following her record-breaking debut, Aneet Padda has been handpicked by Dinesh Vijan to lead his much-anticipated film Shakti Shalini, part of the Maddock Horror Comedy Universe (MHCU). The film, which she signed at just 22, makes her the youngest actor ever to headline a franchise in Indian cinema. An insider adds, “Aneet has an incredible work ethic. She has shown that success hasn’t changed her focus. Balancing college life and stardom isn’t easy, but she’s proving it’s possible with discipline and passion.”Released under Yash Raj Films, Saiyaara became an instant blockbuster and launched Aneet into superstardom alongside co-star Ahaan Panday. The film’s success has been compared to the iconic Kaho Naa... Pyaar Hai, making her debut one for the record books.Shakti Shalini is set to release on December 24, 2026, marking another milestone for Aneet, as the youngest actor to have a major Holiday release, a spot usually reserved for India’s biggest superstars.With her exams around the corner and a big-screen franchise waiting, Aneet Padda truly embodies the new-age Indian dream, balancing education, fame, and ambition with ease.ALos Read: Ayushmann Khurrana Welcomes Aneet Padda to MHCU As Shakti Shalini, Actress Responds。

二 | People with HIV are at increased risk of being reinfected with the virus that causes COVID-19, according to new federal data.Researchers from the Centers for Disease Control and Prevention and the Chicago Department of Public Health followed adult residents in Chicago from their first reported infection from March 2020 through the end of May 2022, according to the report published Wednesday by the CDC.The team compared COVID test laboratory data and COVID vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System.About 5% experienced reinfection among more than 453,000 Chicago residents who tested positive for the virus.Rates of reinfection were higher among people with HIV (6.7%) than among people without HIV (5.2%).People with HIV are more likely to have completed a primary COVID vaccine series plus a booster before their reinfection -- 31.8% versus 27% for those without HIV.Reinfection rates were consistently higher throughout the pandemic for people with HIV and were highest during the original omicron variant phase, according to the report."Understanding if persons with HIV have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance," the authors wrote. "[Persons with HIV] should follow the recommended COVID-19 vaccine schedule, including booster doses, to avoid SARS-CoV-2 reinfections."Those who were reinfected were more likely to be male, older and Black or African American compared to those without HIV, the study found.People with HIV were also less likely to have been unvaccinated at the time of their first infection compared to people without HIV.The report notes the findings are a reminder about the risks of reinfection for those who are immunocompromised.HIV can weaken the immune system, infecting and destroying CD4 cells, which causes the white blood cell count to drop and compromises the immune system.This means that people with HIV are susceptible to COVID infection especially those who are not on antiretroviral therapy (ART).ART is a combination of drugs that suppresses a person's viral load until HIV Is virtually undetectable. The ability of ART to control viral replication has been shown to greatly improve immune system function, studies show."Evaluating the association between HIV infection and SARS-CoV-2 reinfections using surveillance data can help strengthen public health recommendations including the need for extra doses as part of a primary series, booster doses of vaccine, and optimized ART in [persons with HIV]," the authors wrote. "Tailored guidance and prevention messaging for [persons with HIV] can help reduce the elevated risk we identified in this analysis and limit continued SARS-CoV-2 transmission."。